Company news
Control Bionics Ltd. (ASX:CBL) news
Every Control Bionics Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
NeuroStrip secures MHRA registration
August 24, 2026
US FDA Registration and Device Listing for NeuroStrip
August 3, 2026
Commercial momentum builds across both platform pillars
July 30, 2026
Completion of Placement
June 24, 2026
Pause in Trading
June 23, 2026
Commercial Momentum Presentation
June 3, 2026
German Statutory Reimbursement Listing for NeuroNode
March 3, 2026
Joint venture with NextLevel Assistive Technology
February 25, 2026
Half Yearly Report and Accounts
February 25, 2026
PRC-Saltillo - Distribution Agreement
January 28, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 27, 2026
Tobii Dynavox - Distribution Partnership
January 26, 2026
Acquisition of Full Ownership of Neuro Elite Athletics
December 2, 2025
Placement to Raise $3.25 million
December 1, 2025
Control Bionics Integrates with Apple BCI Protocol
November 11, 2025
Rights Issue Offer Booklet
September 3, 2025
Preliminary Final Report
August 28, 2025
Non-Renounceable Rights Issue
August 27, 2025
FY25 Trading Update and NeuroStrip Progress
June 12, 2025
Private Placement
February 24, 2025
First Half FY25 Business Update
December 16, 2024
Expansion into US Sports and Japanese Rehab Markets
December 15, 2024
Coffee Microcaps Meeting Presentation
November 7, 2024
SIGNIFICANT INCREASE IN REVENUE FROM FASTER NDIS APPROVALS
October 3, 2024
ADDENDUM TO NOTICE OF 2024 AGM
September 27, 2024
Placement
September 23, 2024
NON-RENOUNCEABLE RIGHTS ISSUE OFFER AND PRIVATE PLACEMENT AD
September 20, 2024
Non-Renounceable Issue
September 19, 2024
Investor Presentation
September 19, 2024
Trading Halt
September 19, 2024
Exclusive UK and Ireland Distribution Agreement
September 8, 2024
New US Insurance Code Approved
August 18, 2024
Share placement - North Star Impact Fund to invest
July 31, 2024
TGA Approval Granted for DROVE Autonomous Wheelchair Module
June 19, 2024
Control Bionics completes successful $1.04m placement
May 15, 2024
Autonomous Wheelchair Project - US Research Award
January 23, 2024
Completion of Placement of Rights Issue Shortfall
January 18, 2024
Rights Issue Results
November 29, 2023
Pro rata rights issue
October 29, 2023
Control Bionics Unveils the NeuroStrip
October 12, 2023
Extension to Rights Issue Closing Date
June 13, 2023
DROVE - Press Release
April 18, 2023
DROVE - Presentation at Deakin University
April 18, 2023
DROVE - Worlds First Wheelchair Self-drive Controller
April 17, 2023
Appointment of CEO
January 19, 2023
CEO Resignation
September 14, 2022
Appendix 4E
August 24, 2022
Monthly Activities/Appendix 4C Cash Flow Report
April 27, 2022
CBL Enters Japanese Market with NeuroNode Technology
April 11, 2022
Morgans Investment Conference Presentation
November 24, 2021